Risk factors for breakthrough COVID-19 infections in solid organ transplant recipients receiving tixagevimab/cilgavimab for pre-exposure prophylaxis.
Dana L AbrahamAlicia B LichvarAleah L BrubakerNina HasteVictor ChenShira AbelesSaima AslamNancy YamLucy HortonBenjamin C ChenNancy BinkinNancy LawPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2023)